Veru (NASDAQ:VERU) reported quarterly earnings results on February 11, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.26, beating the consensus estimate of $-0.53 by $0.27 per share. Revenue came in at , meeting the estimate of .
Veru's stock moved following the earnings release. The stock currently trades at $2.24 with a market capitalization of $37.1M.


